GB1384214A - Oral contraceptive regimens and packaged unit dosage forms thereof - Google Patents

Oral contraceptive regimens and packaged unit dosage forms thereof

Info

Publication number
GB1384214A
GB1384214A GB1915173A GB1915173A GB1384214A GB 1384214 A GB1384214 A GB 1384214A GB 1915173 A GB1915173 A GB 1915173A GB 1915173 A GB1915173 A GB 1915173A GB 1384214 A GB1384214 A GB 1384214A
Authority
GB
United Kingdom
Prior art keywords
day
cycle
dosage forms
unit dosage
packaged unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1915173A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of GB1384214A publication Critical patent/GB1384214A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GB1915173A 1972-04-24 1973-04-19 Oral contraceptive regimens and packaged unit dosage forms thereof Expired GB1384214A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24701272A 1972-04-24 1972-04-24
US05/250,785 US3932635A (en) 1972-04-24 1972-05-05 Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens

Publications (1)

Publication Number Publication Date
GB1384214A true GB1384214A (en) 1975-02-19

Family

ID=26938396

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1915173A Expired GB1384214A (en) 1972-04-24 1973-04-19 Oral contraceptive regimens and packaged unit dosage forms thereof

Country Status (9)

Country Link
US (1) US3932635A (cg-RX-API-DMAC7.html)
BE (1) BE798585A (cg-RX-API-DMAC7.html)
CA (1) CA1012061A (cg-RX-API-DMAC7.html)
FR (1) FR2182992B1 (cg-RX-API-DMAC7.html)
GB (1) GB1384214A (cg-RX-API-DMAC7.html)
HK (1) HK27276A (cg-RX-API-DMAC7.html)
MY (1) MY7600093A (cg-RX-API-DMAC7.html)
NL (1) NL169681C (cg-RX-API-DMAC7.html)
NZ (1) NZ170401A (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145416A (en) * 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
DE3029726A1 (de) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Postkoitale kontrazeptiva mit norgestrel oder levonorgestrel
US4425339A (en) 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
CA1336328C (en) * 1988-04-11 1995-07-18 Walter G. Leonard Method of increasing bone density in humans
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6214815B1 (en) 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7444305B2 (en) * 2001-02-15 2008-10-28 Mass Connections, Inc. Methods of coordinating products and service demonstrations
US20130203722A1 (en) * 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
MXPA05010871A (es) * 2003-04-11 2005-11-25 Barr Lab Inc Metodos para administrar estrogenos y progestinas.
US20060057186A1 (en) * 2004-09-11 2006-03-16 Margaret Heller Oral contraceptive multivitamin compound and methods of administration
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
WO2015168000A1 (en) 2014-04-28 2015-11-05 The Regents Of The University Of California Estrogen combination for treatment of multiple sclerosis
US10369158B2 (en) * 2014-04-28 2019-08-06 The Regents Of The University Of California Pharmaceutical packaging for estriol therapy
EP3188735A4 (en) 2014-09-02 2018-01-24 The Regents of the University of California Estrogen therapy for brain gray matter atrophy and associated disability
US10406169B2 (en) 2015-03-30 2019-09-10 The Regents Of The University Of California Methods of monitoring estriol therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409721A (en) * 1967-09-15 1968-11-05 Neomed Lab Inc Oral dosage system effective to control the reproduction cycle
NL6903028A (cg-RX-API-DMAC7.html) * 1969-02-26 1970-08-28
US3591688A (en) * 1969-08-22 1971-07-06 American Home Prod Method of preventing ovulation and composition therefor
US3660574A (en) * 1969-09-11 1972-05-02 Warner Lambert Co Method of controlling fertility employing quingestanol acetate
US3755573A (en) * 1970-07-10 1973-08-28 Warner Lambert Co Fertility control empoying quinestrol and quingestanol acetate

Also Published As

Publication number Publication date
FR2182992A1 (cg-RX-API-DMAC7.html) 1973-12-14
NL7305734A (cg-RX-API-DMAC7.html) 1973-10-26
HK27276A (en) 1976-05-21
NZ170401A (en) 1978-07-28
CA1012061A (en) 1977-06-14
NL169681B (nl) 1982-03-16
NL169681C (nl) 1982-08-16
DE2319850A1 (de) 1973-11-08
AU5466473A (en) 1974-10-24
US3932635A (en) 1976-01-13
MY7600093A (en) 1976-12-31
FR2182992B1 (cg-RX-API-DMAC7.html) 1976-07-02
DE2319850B2 (de) 1975-08-07
BE798585A (fr) 1973-10-24

Similar Documents

Publication Publication Date Title
NZ170401A (en) Dispensing package with oral contraceptives in unit dosage form in predetermined sequence
US3568828A (en) Modified sequential oral contraceptive
US4544554A (en) Triphasic oral contraceptive
US4628051A (en) Triphasic oral contraceptive
US4616006A (en) Triphasic oral contraceptive
GB1490099A (en) Contraceptive method and pack
NL300025I1 (nl) Combinatie doseringsvorm voor vrouwen in de pre-menopauze.
FI103951B1 (fi) Ehkäisyjärjestelmä
KR920011514A (ko) 프로게스토겐만을 함유하는 피임제
HK26087A (en) Method of contraception and pharmaceutical package therefor
GB1390803A (en) Medicinal tampons and compositions containing lactulose
NZ307178A (en) Medicament for contraception; contains two, separately packed, sequential hormonal components
GB1385521A (en) Osmotic pressure activated active agent dispenser
US3822355A (en) Novel oral contraceptive method
MX9304931A (es) Anticonceptivos que contienen antiprogestogenos.
Dionne et al. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol
GB1488995A (en) Compositions containing anti-androgenic compounds
GB1483650A (en) Pharmaceutical preparations based on mesterolone
Szontagh et al. Post-coital contraception with dienoestrol
Spona et al. Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate
GB1326528A (en) Method of contraception and compositions used therein
Asbjorn et al. Low dose of gestagen as a contraceptive method. A clinical trial
US3660574A (en) Method of controlling fertility employing quingestanol acetate
Board et al. Sequential oral contraception using DMAP
Koetsawang et al. Comparative studies of two oral contraceptives containing DL norgestrel and D norgestrel

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee